Meds Apotek AB (STO:MEDS)
22.20
-0.20 (-0.89%)
At close: Jun 12, 2026
Meds Apotek AB Revenue
Meds Apotek AB had revenue of 269.94M SEK in the quarter ending March 31, 2026, with 20.89% growth. This brings the company's revenue in the last twelve months to 1.03B, up 18.84% year-over-year. In the year 2025, Meds Apotek AB had annual revenue of 1.01B with 21.37% growth.
Revenue (ttm)
1.03B
Revenue Growth
+18.84%
P/S Ratio
0.40
Revenue / Employee
21.11M
Employees
49
Market Cap
412.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.01B | 177.17M | 21.37% |
| Dec 31, 2024 | 829.23M | 174.03M | 26.56% |
| Dec 31, 2023 | 655.20M | 46.20M | 7.59% |
| Dec 31, 2022 | 609.00M | 415.91M | 215.40% |
| Dec 31, 2021 | 193.09M | -36.40M | -15.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 1, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 1, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BHG Group AB | 10.63B |
| Desenio Group AB | 713.60M |
| Guldbrev Holding AB | 476.27M |
| CDON AB | 454.10M |
| New Bubbleroom Sweden AB | 423.11M |
| Vuxen Group AB | 235.16M |
| Vetted Assets AB | 152.70M |
Meds Apotek AB News
- 5 weeks ago - Meds Apotek AB Earnings Call Transcript: Q1 2026 - Transcripts
- 5 weeks ago - Meds Apotek AB Quarterly report: Q1 2026 - Filings
- 4 months ago - Meds Apotek AB Earnings Call Transcript: Q4 2025 - Transcripts
- 4 months ago - Meds Apotek AB Quarterly report: Q4 2025 - Filings
- 4 months ago - Meds Apotek AB Slides: Q4 2025 - Filings
- 4 months ago - Meds Apotek AB Annual report: Q4 2025 - Filings
- 4 months ago - Meds Apotek AB Annual report: Q4 2025 - Filings
- 6 months ago - Meds Apotek AB Slides: ABGSC Investor Days - Filings